Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# $gmab

Genmab's Epkinly receives FDA approval for relapsed or refractory follicular lymphoma in combination with other treatments. The company also announced a significant financing push to support its acquisition of Merus N.V.

### About $gmab
Genmab A/S is a Danish biotechnology company focused on developing antibody-based therapies for cancer and other serious diseases.  

### Engagements: XXXXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$gmab/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$gmab/time-series/interactions.tsv)  
Current Value: XXXXX  
Daily Average: XXXXX  
X Week: XXXXXX -XX%  
X Month: XXXXXXX -XX%  
X Months: XXXXXXXXX +41%  
X Year: XXXXXXXXX +23%  
1-Year High: XXXXXXX on 2025-09-29  
1-Year Low: XXX on 2025-09-26  

Engagements by network (24h):
X: XXXXX

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$gmab/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$gmab/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XX  
X Week: XXX -XX%  
X Month: XXX +55%  
X Months: XXXXX +160%  
X Year: XXXXX +190%  
1-Year High: XXX on 2025-11-08  
1-Year Low: XX on 2025-01-26  

Mentions by network (24h):
X: XXX

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$gmab/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$gmab/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning $gmab in the last XX hours which is up XX% from XX in the previous XX hours
Daily Average: XX  
X Week: XXX -XX%  
X Month: XXX +144%  
X Months: XXXXX +403%  
X Year: XXXXX +351%  
1-Year High: XXX on 2025-11-08  
1-Year Low: XX on 2025-01-26  

The most influential creators that mention $gmab in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@TheOptionsBull2](/creator/twitter/TheOptionsBull2) | X    | XXX       | X     | XXX         |
| [@Fredbenz0](/creator/twitter/Fredbenz0)             | X    | XXXXX     | X     | XXX         |
| [@NightOwlBiotech](/creator/twitter/NightOwlBiotech) | X    | XXXXX     | X     | XXX         |
| [@EgidiusLambrech](/creator/twitter/EgidiusLambrech) | X    | XXX       | X     | XXX         |
| [@JacobPlieth](/creator/twitter/JacobPlieth)         | X    | XXXXXX    | X     | XX          |
| [@semodough](/creator/twitter/semodough)             | X    | XXXXXX    | X     | XX          |
| [@grok](/creator/twitter/grok)                       | X    | XXXXXXXXX | X     | XX          |
| [@AlertsEdge](/creator/twitter/AlertsEdge)           | X    | XXX       | X     | X           |
| [@Darwin_Knows](/creator/twitter/Darwin_Knows)       | X    | XXX       | X     | X           |

[View More](/list/creators/$gmab/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$gmab/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$gmab/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XXX% no change  
X Month: XXX% +13%  
X Months: XXX% +9%  
X Year: XXX% +39%  
1-Year High: XXX% on 2025-04-19  
1-Year Low: XX% on 2025-01-27  

Most Supportive Themes:
- Community Building: (45%) Discussions around fostering a strong and engaged community.
- Project Development: (30%) Updates and insights into the ongoing development of the project.
- Partnerships & Collaborations: (15%) News and announcements regarding new partnerships and collaborations.
  
Most Critical Themes:
- Market Volatility: (7.5%) Concerns and discussions regarding the fluctuating market price.
- Regulatory Uncertainty: (2.5%) Anxiety surrounding potential regulatory changes and their impact.
  

### Top $gmab Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Top Post-Market Movers (Post-market %) $MRVL Marvell Technology (+8.73%) $HPP Hudson Pacific Properties (+5.21%) $GMAB Genmab (+3.43%) $CRWD CrowdStrike (3.02%) $SN Smith & Nephew (3.60%) $AHR American Healthcare REIT (3.63%) $OKTA Okta (3.75%) $BOX Box (6.06%) $GTLB GitLab (8.90%) $PSTG Pure Storage (10.26%)"  
[X Link](https://x.com/tradedots/status/1996071151291039914) [@tradedots](/creator/x/tradedots) 2025-12-03T04:17Z 1188 followers, XXX engagements


"Looking into some Antibody drug conjugates names. A few sticking out. Large cap wise $GSK $AZN. Smaller names that look good $GMAB $ADCT. $ADCT 500m mcap monthly chart looks nice. $GSK breaking out of downtrend from 1998"  
[X Link](https://x.com/keyboardandmouz/status/1995901357371396444) [@keyboardandmouz](/creator/x/keyboardandmouz) 2025-12-02T17:02Z XX followers, XX engagements


"MHRA (UK) approves #tisotumab vedotin for the treatment of cervical cancer #Tivdak #Genmab #Pfizer $GMAB $PFE"  
[X Link](https://x.com/EgidiusLambrech/status/1995889537545851360) [@EgidiusLambrech](/creator/x/EgidiusLambrech) 2025-12-02T16:15Z XXX followers, XX engagements


"$CCCX $FISV $BTM $CRBU $MAPS $BBWI $CELH $CMG $DDOG $ELF $EXPE $GENI $GMAB $LEG $PINS $VSCO $ANF $BKD $CLF $FIVE $NVTS $OLMA $OSCR $SRPT $TE $CGEM $CJET $CLSK $ENLV $FULT $HNST πŸ’Ž 12/01/25-Part X πŸ’ŽTop Unusual Implied Volatility Watchlist & Database πŸ’ŽIV Change Details For 100+ Stocks (Secondary Unusual Options Alert)"  
[X Link](https://x.com/TheOptionsBull2/status/1995843846282891406) [@TheOptionsBull2](/creator/x/TheOptionsBull2) 2025-12-02T13:13Z XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$gmab

Genmab's Epkinly receives FDA approval for relapsed or refractory follicular lymphoma in combination with other treatments. The company also announced a significant financing push to support its acquisition of Merus N.V.

About $gmab

Genmab A/S is a Danish biotechnology company focused on developing antibody-based therapies for cancer and other serious diseases.

Engagements: XXXXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
X Week: XXXXXX -XX%
X Month: XXXXXXX -XX%
X Months: XXXXXXXXX +41%
X Year: XXXXXXXXX +23%
1-Year High: XXXXXXX on 2025-09-29
1-Year Low: XXX on 2025-09-26

Engagements by network (24h): X: XXXXX

Mentions: XX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XXX -XX%
X Month: XXX +55%
X Months: XXXXX +160%
X Year: XXXXX +190%
1-Year High: XXX on 2025-11-08
1-Year Low: XX on 2025-01-26

Mentions by network (24h): X: XXX

Creators: XX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $gmab in the last XX hours which is up XX% from XX in the previous XX hours Daily Average: XX
X Week: XXX -XX%
X Month: XXX +144%
X Months: XXXXX +403%
X Year: XXXXX +351%
1-Year High: XXX on 2025-11-08
1-Year Low: XX on 2025-01-26

The most influential creators that mention $gmab in the last XX hours

Creator Rank Followers Posts Engagements
@TheOptionsBull2 X XXX X XXX
@Fredbenz0 X XXXXX X XXX
@NightOwlBiotech X XXXXX X XXX
@EgidiusLambrech X XXX X XXX
@JacobPlieth X XXXXXX X XX
@semodough X XXXXXX X XX
@grok X XXXXXXXXX X XX
@AlertsEdge X XXX X X
@Darwin_Knows X XXX X X

View More

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XXX% no change
X Month: XXX% +13%
X Months: XXX% +9%
X Year: XXX% +39%
1-Year High: XXX% on 2025-04-19
1-Year Low: XX% on 2025-01-27

Most Supportive Themes:

  • Community Building: (45%) Discussions around fostering a strong and engaged community.
  • Project Development: (30%) Updates and insights into the ongoing development of the project.
  • Partnerships & Collaborations: (15%) News and announcements regarding new partnerships and collaborations.

Most Critical Themes:

  • Market Volatility: (7.5%) Concerns and discussions regarding the fluctuating market price.
  • Regulatory Uncertainty: (2.5%) Anxiety surrounding potential regulatory changes and their impact.

Top $gmab Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"Top Post-Market Movers (Post-market %) $MRVL Marvell Technology (+8.73%) $HPP Hudson Pacific Properties (+5.21%) $GMAB Genmab (+3.43%) $CRWD CrowdStrike (3.02%) $SN Smith & Nephew (3.60%) $AHR American Healthcare REIT (3.63%) $OKTA Okta (3.75%) $BOX Box (6.06%) $GTLB GitLab (8.90%) $PSTG Pure Storage (10.26%)"
X Link @tradedots 2025-12-03T04:17Z 1188 followers, XXX engagements

"Looking into some Antibody drug conjugates names. A few sticking out. Large cap wise $GSK $AZN. Smaller names that look good $GMAB $ADCT. $ADCT 500m mcap monthly chart looks nice. $GSK breaking out of downtrend from 1998"
X Link @keyboardandmouz 2025-12-02T17:02Z XX followers, XX engagements

"MHRA (UK) approves #tisotumab vedotin for the treatment of cervical cancer #Tivdak #Genmab #Pfizer $GMAB $PFE"
X Link @EgidiusLambrech 2025-12-02T16:15Z XXX followers, XX engagements

"$CCCX $FISV $BTM $CRBU $MAPS $BBWI $CELH $CMG $DDOG $ELF $EXPE $GENI $GMAB $LEG $PINS $VSCO $ANF $BKD $CLF $FIVE $NVTS $OLMA $OSCR $SRPT $TE $CGEM $CJET $CLSK $ENLV $FULT $HNST πŸ’Ž 12/01/25-Part X πŸ’ŽTop Unusual Implied Volatility Watchlist & Database πŸ’ŽIV Change Details For 100+ Stocks (Secondary Unusual Options Alert)"
X Link @TheOptionsBull2 2025-12-02T13:13Z XXX followers, XXX engagements

$gmab
/topic/$gmab